erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.

a case in westbrook shows the disruption and anxiety an outbreak can cause.. november 2014  (25).